Down Syndrome and Postoperative Management: Toward Optimized Approaches in Analgesia and Sedation

Down syndrome (trisomy 21) is a chromosomal anomaly associated with physiological characteristics that can affect responses to analgesics and sedatives. Postoperative pain and sedation management for these patients thus present a significant challenge for healthcare professionals. This is further complicated by conflicting findings from earlier studies regarding opioid and benzodiazepine requirements in these children. This study examines the specific needs for analgesia and sedation in this population.  

What Are the Analgesic and Sedative Needs of Children with Down Syndrome?